OPH-001

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameOPH-001
Drug Alias NameOPH-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase inhibitors
TargetsCaspase
Therapy Area/IndicationsAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado Denver
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAcute Kidney Injury

Other Information

ATC CodeN/A
Related LinksN/A